Halozyme Therapeutics News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Halozyme Therapeutics Incorporated HALO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.68 -4.0% 40.29 20:00:00
Open Price Low Price High Price Close Price Prev Close
41.62 40.27 41.69 40.29 41.97
more quote information »

Recent News

Date Time Source Heading
9/15/202116:05PRNUSHalozyme to Participate in the 2021 Cantor Virtual Global..
9/07/202117:46EDGARStatement of Changes in Beneficial Ownership (4)
9/07/202117:43EDGARStatement of Changes in Beneficial Ownership (4)
8/26/202109:00PRNUSHalozyme to Present at Wells Fargo 2021 Virtual Healthcare..
8/25/202117:55EDGARStatement of Changes in Beneficial Ownership (4)
8/09/202116:08EDGARQuarterly Report (10-q)
8/09/202116:03EDGARCurrent Report Filing (8-k)
8/09/202116:01PRNUSHalozyme Reports Second Quarter 2021 Results
7/30/202108:00PRNUSHalozyme to Participate in Canaccord Genuity 41st Annual..
7/27/202116:05PRNUSHalozyme To Host Second Quarter 2021 Financial Results..
7/15/202119:37EDGARStatement of Changes in Beneficial Ownership (4)
7/12/202108:12PRNUSHalozyme Announces Janssen Receives U.S. FDA Approval of..
7/06/202118:09EDGARStatement of Changes in Beneficial Ownership (4)
7/06/202117:20EDGARStatement of Changes in Beneficial Ownership (4)
6/22/202113:48PRNUSHalozyme Announces Janssen Receives European Marketing..
6/22/202108:17TRMNHalozyme Collaborates with ViiV Healthcare to Develop..
6/22/202102:37DJNGlaxoSmithKline Says ViiV, Halozyme Signed Deal for..
6/22/202102:22BWViiV Healthcare & Halozyme enter global collaboration &..
6/22/202102:18PRNUSViiV Healthcare and Halozyme enter global collaboration and..
6/07/202118:53EDGARStatement of Changes in Beneficial Ownership (4)
6/01/202116:01PRNUSHalozyme Highlights Data Presentations by Collaborators for..
5/28/202116:40PRNUSHalozyme to Present at Upcoming Investor Conferences
5/21/202111:02SEEKJNJ wins positive opinion in Europe for expanded use of..
5/21/202110:02PRNUSHalozyme Announces Janssen Receives Two Positive CHMP..
5/11/202118:23EDGARStatement of Changes in Beneficial Ownership (4)
5/10/202116:10EDGARQuarterly Report (10-q)
5/10/202116:04EDGARCurrent Report Filing (8-k)
5/10/202116:03SEEKHalozyme Therapeutics EPS beats by $0.05, beats on revenue
5/10/202116:01PRNUSHalozyme Reports First Quarter 2021 Results
5/09/202117:35SEEKHalozyme Therapeutics Q1 2021 Earnings Preview
5/07/202116:33EDGARCurrent Report Filing (8-k)
5/05/202116:24EDGARSecurities Registration: Employee Benefit Plan (s-8)
5/05/202116:03EDGARCurrent Report Filing (8-k)
5/03/202116:04EDGARCurrent Report Filing (8-k)
4/29/202116:05PRNUSHalozyme to Present at BofA Securities 2021 Virtual Health..
4/20/202116:05PRNUSHalozyme To Host First Quarter 2021 Financial Results..
4/14/202116:20EDGARStatement of Changes in Beneficial Ownership (4)
4/05/202119:51EDGARStatement of Changes in Beneficial Ownership (4)
4/01/202119:45EDGARStatement of Changes in Beneficial Ownership (4)
4/01/202119:44EDGARStatement of Changes in Beneficial Ownership (4)
3/26/202116:08EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
3/26/202116:05EDGARProxy Statement (definitive) (def 14a)
3/01/202116:08EDGARCurrent Report Filing (8-k)
2/25/202106:08EDGARCurrent Report Filing (8-k)
2/25/202105:02SEEKHalozyme Therapeutics prices $700M of private debt offering
2/24/202122:41PRNUSHalozyme Therapeutics, Inc. Announces Pricing of Private..
2/23/202116:17EDGARCurrent Report Filing (8-k)
2/23/202116:17SEEKHalozyme proposes offering of $500M convertible senior notes..
2/23/202116:13EDGARAnnual Report (10-k)
2/23/202116:10PRNUSHalozyme Therapeutics, Inc. Announces Proposed Offering of..
See more news about this stock »

Your Recent History
Halozyme T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.